Showing results (1381-1390 of 2,583) with videos related to
Sort By:
Pageof 259
Molecular Oncology|May 20, 2021
imPlatelet classifier: image-converted RNA biomarker profiles enable blood-based cancer diagnosticsKrzysztof Pastuszak, Anna Supernat, Myron G Best, et al.Molecular Oncology|May 18, 2021
The ERRα-VDR axis promotes calcitriol degradation and estrogen signaling in breast cancer cells, while VDR-CYP24A1-ERRα overexpression correlates with poor prognosis in patients with basal-like breast cancerKatia Danza, Letizia Porcelli, Simona De Summa, et al.Molecular Oncology|June 4, 2020
The STAT3-miR-223-TGFBR3/HMGCS1 axis modulates the progression of cervical carcinomaJu Zhang, Ming Jiang, Lili Qian, et al.Molecular Oncology|June 3, 2020
The MSP-RON axis stimulates cancer cell growth in models of triple negative breast cancerRhona Millar, Anna Kilbey, Sarah-Jane Remak, et al.Molecular Oncology|May 21, 2021
Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective studyDorte Schou Nørøxe, Aidan Flynn, Christina Westmose Yde, et al.Molecular Oncology|February 24, 2023
Cell-free chromatin immunoprecipitation can determine tumor gene expression in lung cancer patientsChristoffer Trier Maansson, Peter Meldgaard, Magnus Stougaard, et al.Molecular Oncology|February 22, 2023
Codon adaptation by synonymous mutations impacts the functional properties of the estrogen receptor-alpha protein in breast cancer cellsLéa Clusan, Frederic Percevault, Emmanuelle Jullion, et al.Molecular Oncology|November 19, 2016
Exosomal proteins as prognostic biomarkers in non-small cell lung cancerB Sandfeld-Paulsen, N Aggerholm-Pedersen, R Bæk, et al.Molecular Oncology|May 3, 2014
OPG and PgR show similar cohort specific effects as prognostic factors in ER positive breast cancerNicole Sänger, Eugen Ruckhäberle, Giampaolo Bianchini, et al.Molecular Oncology|October 21, 2016
Epigenetic determinants of metastasisSaroor A Patel, Sakari VanharantaPageof 259